Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Effects of short term metformin administration on androgens in normal men.

Shegem NS, Nasir AM, Jbour AK, Batieha AM, El-Khateeb MS, Ajlouni KM.

Saudi Med J. 2002 Aug;23(8):934-7.

PMID:
12235466
2.

Effects of short term metformin administration on androgens in diabetic men.

Shegem NS, Alsheek Nasir AM, Batieha AM, El-Shanti H, Ajlouni KM.

Saudi Med J. 2004 Jan;25(1):75-8.

PMID:
14758385
3.

The effects of metformin and diet on plasma testosterone and leptin levels in obese men.

Ozata M, Oktenli C, Bingol N, Ozdemir IC.

Obes Res. 2001 Nov;9(11):662-7.

4.

Increased insulin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy.

Berker B, Emral R, Demirel C, Corapcioglu D, Unlu C, Kose K.

Gynecol Endocrinol. 2004 Sep;19(3):125-33.

PMID:
15697073
6.

Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.

Kazerooni T, Dehghan-Kooshkghazi M.

Gynecol Endocrinol. 2003 Feb;17(1):51-6.

PMID:
12724019
7.

The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.

Yilmaz M, Biri A, Karakoç A, Törüner F, Bingöl B, Cakir N, Tiras B, Ayvaz G, Arslan M.

J Endocrinol Invest. 2005 Dec;28(11):1003-8.

PMID:
16483179
8.

Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome.

Diamanti-Kandarakis E, Alexandraki K, Piperi C, Aessopos A, Paterakis T, Katsikis I, Panidis D.

Metabolism. 2007 Jan;56(1):129-34.

PMID:
17161235
9.

The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome.

Yucel A, Noyan V, Sagsoz N.

Eur J Obstet Gynecol Reprod Biol. 2006 May 1;126(1):81-6. Epub 2005 Dec 7.

PMID:
16337726
10.

Metformin administration improves leukocyte count in women with polycystic ovary syndrome: a 6-month prospective study.

Orio F, Manguso F, Di Biase S, Falbo A, Giallauria F, Labella D, Tolino A, Lombardi G, Colao A, Palomba S.

Eur J Endocrinol. 2007 Jul;157(1):69-73.

11.

Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome.

Kriplani A, Agarwal N.

J Reprod Med. 2004 May;49(5):361-7.

PMID:
15214709
12.

The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.

Yilmaz M, Bukan N, Ayvaz G, Karakoç A, Törüner F, Cakir N, Arslan M.

Hum Reprod. 2005 Dec;20(12):3333-40. Epub 2005 Aug 25.

13.

Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.

Baillargeon JP, Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Nestler JE.

Fertil Steril. 2004 Oct;82(4):893-902.

PMID:
15482765
14.

The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta-analysis.

Barba M, Schünemann HJ, Sperati F, Akl EA, Musicco F, Guyatt G, Muti P.

Clin Endocrinol (Oxf). 2009 May;70(5):661-70. doi: 10.1111/j.1365-2265.2008.03459.x. Epub 2008 Oct 21.

PMID:
19178532
15.

Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.

Berria R, Gastaldelli A, Lucidi S, Belfort R, De Filippis E, Easton C, Brytzki R, Cusi K, Jovanovic L, DeFronzo R.

Clin Pharmacol Ther. 2006 Aug;80(2):105-14. Epub 2006 Jun 30.

PMID:
16890572
16.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
17.

[Effects of metformin on hyperinsulinemic anovulation].

Li R, Lin J, Zhou J.

Zhonghua Fu Chan Ke Za Zhi. 2001 May;36(5):296-8. Chinese.

PMID:
11783382
18.

Effect of metformin on the clinical and metabolic assessment of women with polycystic ovary syndrome.

Santana LF, de Sá MF, Ferriani RA, de Moura MD, Foss MC, dos Reis RM.

Gynecol Endocrinol. 2004 Aug;19(2):88-96.

PMID:
15624270
19.

The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome.

Yilmaz M, Karakoç A, Törüner FB, Cakir N, Tiras B, Ayvaz G, Arslan M.

Gynecol Endocrinol. 2005 Sep;21(3):154-60.

PMID:
16335907
20.

Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.

Herrmann BL, Berg C, Vogel E, Nowak T, Renzing-Koehler K, Mann K, Saller B.

Horm Metab Res. 2004 Jan;36(1):54-61.

PMID:
14983408
Items per page

Supplemental Content

Write to the Help Desk